Quantum BioPharma Ltd. ( QNTM) - Key Metrics
QNTM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.48 | -$0.26 | -$0.26 |
| 2026Q1 | $0 | -$2.98 | -$0.37 | -$0.37 |
| 2025Q4 | $0 | -$0.78 | -$0.08 | -$0.08 |
| 2025Q3 | $0 | -$1.40 | -$0.45 | -$0.45 |
| 2025Q2 | $0 | -$3.06 | -$0.65 | -$0.65 |
QNTM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.89 |
| 2026Q1 | 0% | -0.41 |
| 2025Q4 | 0% | -2.31 |
| 2025Q3 | 0% | -2.93 |
| 2025Q2 | 0% | -1.65 |
QNTM
Price: $2.43
52 week price:
Earnings Per Share: -7.73 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 19.8 million